Clinical Trials Logo

Clinical Trial Summary

To evaluate the effects of oxytocin infusion during abdominal myomectomy.


Clinical Trial Description

Myomectomy is indicated for symptomatic uterine fibroids. Fibroids have blood supply and 20% of the abdominal myomectomy cases might require blood transfusion because of the nature of the surgery. Oxytocin infusion is one of the intervention to decrease blood loss during myomectomy. To evaluate the effects and benefits of oxytocin infusion during abdominal myomectomy we decide to conduct this randomized study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03308643
Study type Interventional
Source Kanuni Sultan Suleyman Training and Research Hospital
Contact
Status Completed
Phase Phase 4
Start date October 1, 2017
Completion date May 10, 2018

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04080375 - Preoperative Vaginal Dinoprostone Prior to Abdominal Myomectomy Phase 3
Completed NCT03634306 - Ultravision Visual Clearing System in Laparoscopic Hysterectomy and Myomectomy N/A
Recruiting NCT03363425 - Effect of Perioperative iv Dexmedetomidine vs. Lidocaine on Postoperative Pain, Analgesic Consumption and Recovery After Abdominal Gynaecological Surgery Phase 2/Phase 3
Not yet recruiting NCT04358965 - Tranexamic Acid Versus Vaginal Misoprostol in Abdominal Myomectomy Phase 4
Not yet recruiting NCT04357015 - Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy Phase 4
Completed NCT03250221 - Comparison of Robot-assisted Laparoscopic Myomectomy and Traditional Laparoscopic Myomectomy With Barbed Sutures
Completed NCT02741531 - The Effect of Partial Bladder Filling on Post-operative Time to Void in Minimally Invasive Gynecologic Procedures N/A
Completed NCT02049242 - Uterine Tourniquet at Open Myomectomy N/A
Completed NCT00978601 - Improved Recovery Using Multimodal Peri-operative Analgesia in Minimally Invasive Myomectomy N/A
Not yet recruiting NCT04357002 - Intravenous Tranexamic Acid Versus Vaginal Dinoprostone in Abdominal Myomectomy Phase 4
Completed NCT03892668 - Intravenous Oxytocin Versus Tranexamic Acid in Reducing Blood Loss During Abdominal Myomectomy. Phase 4